Growth Metrics

Dexcom (DXCM) Capital Expenditures Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.64%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 8.49%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 10.17%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 16.83%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.81%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.15%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.35%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 8.08%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -8.05%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.84%
Dec 31, 2025 17.08%
Sep 30, 2025 -9.39%
Jun 30, 2025 0.94%
Mar 31, 2025 -5.04%
Dec 31, 2024 15.82%
Sep 30, 2024 0.95%
Jun 30, 2024 -13.24%
Mar 31, 2024 -17.05%
Dec 31, 2023 -4.46%
Sep 30, 2023 2.07%
Jun 30, 2023 0.46%
Mar 31, 2023 31.04%
Dec 31, 2022 12.92%
Sep 30, 2022 29.61%
Jun 30, 2022 24.95%
Mar 31, 2022 37.25%
Dec 31, 2021 65.48%
Sep 30, 2021 65.61%
Jun 30, 2021 114.18%
Mar 31, 2021 86.78%
Dec 31, 2020 50.67%
Sep 30, 2020 51.99%
Jun 30, 2020 69.27%
Mar 31, 2020 13.18%
Dec 31, 2019 35.82%
Sep 30, 2019 45.61%
Jun 30, 2019 64.69%
Mar 31, 2019 50.63%
Dec 31, 2018 15.13%
Sep 30, 2018 47.61%
Jun 30, 2018 17.81%
Mar 31, 2018 24.13%
Dec 31, 2017 56.41%
Sep 30, 2017 53.95%
Jun 30, 2017 44.22%
Mar 31, 2017 80.41%
Dec 31, 2016 97.06%
Sep 30, 2016 94.15%
Jun 30, 2016 73.80%
Mar 31, 2016 101.77%
Dec 31, 2015 102.35%
Sep 30, 2015 36.65%
Jun 30, 2015 29.51%
Mar 31, 2015 51.51%
Dec 31, 2014 9.09%
Sep 30, 2014 34.94%
Jun 30, 2014 51.08%
Mar 31, 2014 29.62%
Dec 31, 2013 -0.94%
Sep 30, 2013 1.68%